Revolutionizing bladder tumor treatment with non-thermal atmospheric plasma treatment under local anesthesia: a case report.

Non-muscle-invasive bladder cancer exhibits low progression risk with high recurrence rate. Standard resection requires general anesthesia and carries inherent risks. CAPS Medical™ PlasmaSure™ is an innovative system that employs non-thermal atmospheric plasma in a minimally invasive procedure, and a first-in-human study has previously demonstrated its ability to safely and efficiently ablate superficial bladder tumors. The current case report shows that the same procedure can be conducted without the need for general anesthesia. These findings highlight a future potential for PlasmaSure™ to enable in-office efficient ablation of superficial bladder tumors, thereby minimizing anesthesia-related risks and enhancing patient quality of life.